Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day, Leticia Hosta‐Rigau, Diego Oyarzun, Hideyuki Okano, Víctor de Lorenzo, Conrad von Kameke, Habiba Alsafar, Cong Cao, Guo-Qiang Chen, Weizhi Ji , Richard J. Roberts, Mostafa Ronaghi, Karen Yeung, Feng Zhang, Sang Yup Lee

Research output: Contribution to journalArticlepeer-review

Abstract

Patient X: A 67‐year‐old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X‐rays reveal a fractured hip, which will require total hip replacement surgery.
Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalBiotechnology Journal
Volume14
Issue number1
Early online date24 May 2018
DOIs
Publication statusPublished - 10 Jan 2019

Keywords

  • biotechnology
  • gene editing
  • precision medicine
  • stem cells
  • tissue engineering

Fingerprint

Dive into the research topics of 'Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health'. Together they form a unique fingerprint.

Cite this